Cargando…
Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine
Tobacco smoking continues to be a global epidemic and the leading preventable cause of cancer and cardiovascular disease. Nicotine vaccines have been investigated as an alternative to currently available smoking cessation strategies as a means to increase rates of success and long-term abstinence. R...
Autores principales: | Fraleigh, Nya L., Lewicky, Jordan D., Martel, Alexandrine L., Diaz-Mitoma, Francisco, Le, Hoang-Thanh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913222/ https://www.ncbi.nlm.nih.gov/pubmed/33546163 http://dx.doi.org/10.3390/vaccines9020118 |
Ejemplares similares
-
Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
por: Fraleigh, Nya L., et al.
Publicado: (2019) -
Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small “Non-Natural” Peptides
por: Le, Hoang-Thanh, et al.
Publicado: (2020) -
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats
por: Oliva, Reynaldo, et al.
Publicado: (2019) -
Exploiting the DNA Damaging Activity of Liposomal Low Dose Cytarabine for Cancer Immunotherapy
por: Lewicky, Jordan D., et al.
Publicado: (2022) -
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)
por: Fraleigh, Nya L., et al.
Publicado: (2016)